BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs2476601
,
ERBB2
,
Coagulation
,
Pseudomonas infection
,
Stem cell
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ICI
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Breast cancer MCF-7 cells treated with selective estrogen receptor modulators
MCF7 breast cancer cells treated with tamoxifen metabolites in the presence or absence of estrogen.
Explore Curated Studies Results
Literature
Most Relevant Literature
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRI…
Probiotic Potential, Safety Properties, and Antifungal Activities of Corynebacterium amycolatum ICIS…
First-line ICIs in renal cell carcinoma.
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients w…
ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinol…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dietary Intervention for NSCLC Patients Treated With ICI
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ